Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery
Contamination Control Strategy (CCS) has moved from regulatory checkbox to operational discipline across sterile manufacturing. But what does that shift actually look like inside a supplier’s operations, and why should customers care?
In this video interview, Aptar Pharma’s Nicolas Voisin and Audrey Chardonnet (Injectables division) discuss how CCS reshaped daily practice at Aptar Pharma, and what that means for the customers who rely on their sterile components.